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Abstract  
Importance 
Early onset major depressive disorder (MDD) is common in those at high familial-risk of 
depression and is associated with particularly poor long-term mental health, social and 
educational outcomes.   
Objective 
To examine the developmental pathways that lead to first episode adolescent-onset MDD 
(incident cases) in those at high familial risk.  We postulated a theoretically-informed model 
that enabled the simultaneous testing of different pathways to incident adolescent-onset 
MDD.  These pathways were composed of contributions from familial/genetic and social risk 
factors as well as effects via specific clinical antecedents.   
Design 
Four year longitudinal study of offspring of depressed parents.   
Setting 
General community 
Participants  
337 families where the index parent (315 mothers and 22 fathers) had experienced at least 
two episodes of MDD (recruited through primary care) and, at baseline, there was a 
biologically related child in the age range 9-17 years living with the index parent (197 girls 
and 140 boys, mean age = 12.4 years). Offspring with MDD prior to the study or at baseline 
(27), or with an episode of MDD that had remitted by follow-up (4) and missing baseline 
MDD data (2) were excluded.  92% of families completed the follow-up.   
Main outcome measure  
Primary outcome: new-onset MDD; Secondary outcome: total DSM-IV MDD symptom score. 
Results 
Fear/anxiety (β=.38, p<.01) and irritability (β=.12, p<.05) were significant independent 
antecedents of new adolescent-onset MDD but low mood (β= -.03, p>.1) and disruptive 
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behavior (β= -.08, p>.1) were not.  Results were similar for DSM-IV symptom count at follow-
up.  All the measured familial/genetic and social risk indicators directly influenced risk for 
new-onset MDD rather than indirectly through acting on dimensional clinical antecedents.    
Conclusions and relevance 
There are multiple pathways to first-onset adolescent depression in those at familial risk.  
Anxiety and irritability may be additional clinical phenomena to be included as targets in 
primary preventive interventions focusing on the child.  As well as targeting clinical 
phenomena in parents and children, depression prevention methods in high-risk groups may 
need to take into consideration social risks such as poverty and psychosocial adversity.  
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Background 
 
Major depressive disorder (MDD) is a leading global cause of lifelong disability.  The 
incidence markedly rises during mid-adolescence1-3 and first onset at this age predicts a 
chronic long-term trajectory of symptoms into adult life4-6 with especially poor long-term 
mental health, social and educational outcomes2,4-7.  Even when the onset of depression is 
in adult life many of its contributing risk factors begin during childhood8-9, highlighting the 
importance of understanding the etiology of early-onset MDD10. The most common major 
risk factor for early-onset MDD is depression in a parent 6,11-13.  The adolescent offspring of 
depressed parents are therefore an important group for investigating the initial development 
of early-onset MDD.  
MDD has a complex multi-factorial etiology that includes inherited/familial 
influences13-18 and social risk factors8,9,19,20. How do such risks collectively impact on the 
child and eventually translate into first onset MDD?  The childhood symptom dimensions of 
depression (low mood), anxiety/fear and conduct and oppositional problems have 
individually been found to precede later mood disorder 21-24 25,26.  Irritability may be a distinct 
dimension of oppositional behavior that independently predicts depressive 
symptomatology27-29. Familial/genetic and social risk factors may therefore increase the 
probability of incident MDD through earlier effects on these symptom dimensions which 
appear to be antecedents to disorder.   
Despite a consensus that depression has multi-factorial causes and likely involves 
multiple risk pathways that begin in childhood, high-risk studies to date have documented 
elevated life-time rates of depressive disorder in those at familial risk but have not tested 
which developmental processes are involved in the initial onset of MDD in these individuals.  
This would be informative for refining primary prevention methods.  Depression prevention 
efforts currently focus on modifying low mood, with particularly promising results when 
prevention is targeted at those at elevated risk for MDD including the offspring of depressed 
parents30-32.  However, there are different developmental routes into first-onset MDD: if these 
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can be identified, targeting relevant risk factors and clinical antecedents could potentially be 
useful adjuncts to existing prevention programs33.    
A focus on identifying processes involved in the first-onset of adolescent depression 
is warranted given the very high rates of recurrence when depression arises at this time4.   
This is the first paper to examine the antecedents of the initial onset of major depressive 
disorder during adolescence in a high-risk sample using an approach that models risk 
factors simultaneously and accounts for the co-occurrence of such risks.  We set out to test 
whether multiple indicators of familial risk and social adversity simultaneously impact on first-
onset MDD via anxiety, low mood, disruptive behavior and irritability in a high-risk 
longitudinal study of child and adolescent offspring of parent(s) with a history of recurrent 
major depressive disorder.   
Methods 
Participants 
Data were from a prospective longitudinal study of the offspring of parents with 
recurrent depression.  At baseline, there were 337 families (315 mothers and 22 fathers) 
recruited primarily from UK general practices34. The presence of least two episodes of DSM-
IV major depressive disorder (MDD) in the index parent was confirmed at baseline with a 
timeline of the index parent’s previous depressive episodes35,36 and the SCAN (Schedules 
for Clinical Assessment in Neuropsychiatry)37 assessed current parental depression. One 
child per family was included.  The youngest child between 9 to 17 years was selected to 
reduce the likelihood that children had already experienced MDD (197 girls and 140 boys, 
mean age = 12.4 years).  All children were biologically related to and living with the affected 
parent.  Additional exclusion criteria were moderate-severe intellectual disability (IQ<50) in 
the child and DSM-IV criteria for bipolar disorder, mania/hypomania or psychotic disorder in 
the parent at interview. Two families were excluded as the index parent was subsequently 
diagnosed with bipolar disorder. Parents and offspring were assessed on three occasions. 
The average time between the baseline (T1) and second assessment (T2) was 16.2 months 
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and between the second and third (T3) assessment was 12.5 months. Data were collected 
via semi-structured diagnostic interviews and questionnaires38. Written informed consent or 
assent was obtained from parents and children as appropriate. The Multi-Center Research 
Ethics Committee for Wales approved the study.  
 
Outcome variables at follow-up (T2 and T3) 
Primary outcome: New-onset major depressive disorder (MDD) in offspring 
Child psychopathology was assessed with the Child and Adolescent Psychiatric Assessment 
(CAPA),39 which is a semi-structured diagnostic interview that derives psychiatric symptoms 
and diagnoses over the preceding three months39,40.   The parent and child assessments 
were completed independently by trained, supervised interviewers.  A modified section of the 
CAPA was used to collect information on MDD symptoms occurring prior to the study and in 
between assessments.  MDD was defined as the presence of at least 5 depressive 
symptoms including one of the core symptoms of low mood/irritability or loss of interest plus 
depression-related impairment (assessed with the incapacity section of the CAPA)41.  
Diagnosed and sub-threshold cases were reviewed by two experienced child and adolescent 
psychiatrists.  The primary outcome was new-onset offspring MDD defined as MDD at either 
T2 or T3 assessment.  To increases confidence that we were identifying first-onset MDD 
cases, we excluded those with a diagnosis of MDD prior to T1 or at T1 (n=27), an episode 
that occurred but remitted between follow-up assessments (n=4) and those with missing 
MDD diagnostic information at baseline (n=2)). This resulted in a maximum sample of 304 
families. Diagnostic data at follow-up were available for 279 individuals (92%).  
 
Secondary outcome: Major depressive disorder (MDD) symptoms in offspring 
A total of all DSM-IV MDD symptoms defined by the CAPA at follow-up (an average of the 
total symptoms aggregated across T2 and T3) was calculated.   
8 
 
 
Predictor variables assessed at baseline (T1) 
Dimensional clinical antecedents 
Low mood symptoms  
The Mood and Feelings Questionnaire (MFQ) is a widely accepted depression 
screening instrument and was used to generate a full range of low mood scores42.  It 
includes 34 items about the child’s mood symptoms over the past three months rated from 0 
(not true) to 2 (true)43.  Scores across informants were combined by using the highest rating 
per item from either the parent or the child.  Internal reliability was excellent (α = .95).  We 
did not use the CAPA depression score as a predictor to avoid the possibility of criterion 
contamination when predicting new-onset MDD at follow-up diagnosed using the CAPA and 
because the threshold for endorsing an MDD symptom is very high41.   
Anxiety/fear  
The Screen for Child Anxiety and Related Emotional Disorders (SCARED) is a 41-item 
questionnaire44,45 that assesses children’s symptoms of anxiety (generalized, panic, somatic, 
school, separation and social anxiety) rated from 0 (not true/hardly ever true) to 2 (very 
true/often true)45,46. Internal reliability was excellent (α = .93). Parent and child data were 
combined as above for low mood. 
Disruptive behavior and irritability 
Symptoms of oppositional defiant disorder were assessed with the CAPA. Irritability 
scores were calculated by combining the items (0 absent; 1 present): ‘touchy or easily 
annoyed’, ‘angry or resentful’ and ‘temper tantrums’47,48.  The items ‘disobedient/break rules’, 
‘annoys others’, ‘blames others’ and ‘spiteful or vindictive’ created a disruptive behavior 
score. Both scales showed adequate internal consistency (α = .61; α = .61).   
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Indices of degree of familial risk  
Severity of parental MDD16,34 and familial loading for MDD in additional family 
members17 indexed the degree of offspring familial risk.  Using a life history calendar35,36 
parents reported on any hospitalizations for depression and gave details of their previous 
worst two episodes of depression and associated impairment49.  A severe episode of 
depression was defined as a period of hospitalization due to depression or an episode of 
depression with severe impairment in at least one  area of functioning (GAF score ≤ 50)38,49.  
Family history of depression additional to the index parent was ascertained by asking 
parents about a diagnosis of depression in first- and second-degree relatives of the child.  
The number of family members with a history of depression was weighted by relatedness17. 
Social adversity indices  
 A measure of recent psychosocial adversity was derived from recent stressful life 
events50. A total score was calculated by summing stressful events (possible n=21) 
occurring within the past 12 months.  Sample items include: ‘death of a close friend’, ‘serious 
illness’, being bullied’, ‘increased quarrelling between parents’. Where a life event was 
reported by the parent or the child, it was considered present51. 
 Low parent-reported household income was considered as a measure of economic 
disadvantage and defined as gross household income < £20,00052 which in this sample is 
equivalent to the international definition of poverty (<60% of median income)53.   
 
Statistical analysis  
 Structural equation modelling (SEM), which enables simultaneous assessment of all 
hypothesized risk paths was carried out.  Figure 1 shows the full estimated model, and 
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results are presented as standardized beta coefficients.  We hypothesized that low mood, 
fear/anxiety, irritability and disruptive behavior would each independently behave as 
antecedents, even allowing for correlations between them, given previous evidence for each 
as a clinical antecedent of MDD21,23,24,26,48.  Furthermore it was hypothesized that indicators 
of familial (parental depression severity, additional family history of depression) and social 
risk (recent psychosocial adversity, economic disadvantage) would have both direct and 
indirect effects (via the clinical antecedents) on new-onset MDD.  Analyses were conducted 
using LISREL54.  A polyserial covariance matrix was estimated in PRELIS prior to analyses 
as some variables were binary.  304 cases were available.  Little’s test indicated that data 
were missing completely at random (χ2 (18) = 16.13, p = .583).  Full Information Maximum 
Likelihood estimation enabled use of all available data.  Fit of the final model was excellent 
(χ² (10) = 7.75, p = .653; RMSEA = .00 (.00, .05); CFI = 1.00; SRMR = .01).  Indirect effects 
were estimated controlling for the effect of the paths from other risk factors to the clinical 
antecedents.  Analysis was conducted between September 1 2015-to May 27 2016 and 
revisions between 10 August-20th September, 2016.  
 
Results 
Descriptive statistics are shown in Table 1.   On average, individuals had 1.85 DSM-IV 
symptoms of MDD at follow-up (range= 0-8; standard deviation = 1.74).  20 individuals had 
new-onset MDD during the study (6 male, 14 female; average age at onset =14.4 years, 
range 10-18).   
<TABLE 1 HERE> 
 
The results of SEM analyses for the primary outcome of new-onset MDD are shown in 
Figure 1 and described below.   
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<FIGURE 1 HERE>   
Dimensional clinical antecedents 
Irritability was associated with new-onset MDD (β= .12, p<.05), as was fear/anxiety 
(β= .38, p<.01).  In contrast, allowing for other effects in the full model, disruptive behavior 
was not associated with new-onset MDD (β= -.08, p>.1), nor was low mood (β= -.03, p>.1).  
To compare the magnitude of the two paths showing significant association with new-onset 
MDD (irritability and fear/anxiety) we constrained them to be equal which resulted in a 
significant χ² change (χ² (1) =9.09, p =.003) indicating that the path from fear/anxiety to new-
onset MDD was significantly stronger than the path for irritability.  The correlation between 
fear/anxiety and irritability was low but significant (Figure 1; β =.14, p<.05) suggesting they 
do not frequently co-occur.  
Indices of familial risk   
The direct paths from additional family history of depression to new-onset MDD 
(β=.10, p<.05) and from parent depression severity to new-onset MDD (β= 24, p<.01), were 
significant.  Neither of the indices of familial risk were associated with any clinical 
antecedent.   
Indices of social risk  
Both economic disadvantage and recent psychosocial adversity had significant direct 
effects on new-onset MDD (β= .12, p<.05; β= .22, p<.01, respectively).  In addition, 
economic disadvantage and recent psychosocial adversity were associated with all the 
clinical antecedents.   
Indirect effects 
We hypothesised that indices of familial and social risk would influence risk for new-
onset MDD indirectly via the dimensional clinical antecedents as well as directly.  None of 
the indirect effects was significant: economic disadvantage to new-onset MDD via irritability 
(β=.007, p>.1); economic disadvantage to new-onset MDD via fear/anxiety (β=-.012, p>.1) 
recent psychosocial adversity via fear/anxiety (β= -.012, p>.1) and irritability (β= .003, p>.1). 
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Secondary analyses 
CAPA-derived DSM-IV MDD symptoms were assessed as a secondary outcome 
(see supplementary table 1).  The pattern of results was extremely similar to those for the 
primary outcome.  The only exception was that the paths to MDD symptoms from irritability 
and from fear/anxiety were not significantly different (χ² (1) = 0.27, p = .605).  The small 
number of affected boys (Table 1) precluded examination of gender differences for new-
onset MDD.  We also thought it important to examine age effects by excluding any pre-
pubertal onset MDD cases (< 10 years) given evidence these may differ from pubertal-onset 
cases22 and cases where irritability was the defining MDD mood symptom.  However, there 
were no such cases.  Additional sensitivity analyses (supplementary section) examined 
which of the separate aspects of fear/anxiety (e.g. generalized anxiety, social anxiety etc) 
was most associated with new-onset MDD and results suggested that generalized anxiety 
symptoms were driving the predictive effect of fear/anxiety on new-onset MDD.  
 
Discussion  
In a longitudinal high-risk study of MDD we examined mechanisms underlying the 
development of first episode of adolescent-onset MDD in those at high familial-risk.  
Simultaneous testing of different pathways suggested six routes into adolescent-depression 
(two via clinical antecedents and four via familial/genetic and social risk factors).  Both 
fear/anxiety and irritability predicted new adolescent-onset MDD and MDD symptom count.  
These effects were independent of each other as well as of low mood and disruptive 
behavior.  These antecedents are often examined individually and are correlated with each 
other; to our knowledge, their joint contribution has not been examined together in this way.  
The observation that irritability and not other aspects of oppositional behavior increased risk 
for new-onset MDD is consistent with results from population-based studies48,55,23,26.   Sub-
threshold low mood symptoms are known to predate depression21,24.  Thus, the finding that 
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fear/anxiety predicted new-onset MDD over and above the effect of low mood may seem 
surprising but these dimensions are highly correlated (Figure 1).  Whilst, anxiety and 
depression cross predict each other over time,26,56-62 anxiety typically emerges earlier 22 
which may contribute to the stronger predictive effect observed for  fear/anxiety on first 
adolescent-onset MDD.   Sensitivity analyses illustrated that generalized anxiety symptoms 
were driving the predictive effect of fear/anxiety on new-onset MDD.  Overall, our findings 
suggest that considering additionally targeting anxiety and/or irritability63,64 in the child seems 
warranted. Investigating the neural/behavioral correlates of fear/anxiety and irritability may 
help elucidate how these dimensions increase MDD risk65.  
We predicted that indicators of familial loading and social risk would influence risk for 
MDD indirectly via effects on dimensional clinical antecedents.  We did not find evidence for 
this and all the indirect paths were non-significant.  In contrast, there were significant direct 
effects of all familial/genetic and social risk factors on MDD.  The indicators of familial and 
social risk thus predicted MDD independently of correlated familial risk, parental depression 
severity and clinical antecedents in the child.  This has important implications for treatment 
and prevention and highlights the need to not only resolve clinical phenomena in the child 
but also wider contextual difficulties.  Effective prevention of adolescent MDD is important 
given the potential for long-term beneficial effects on adult functioning66. Our findings 
suggest that primary prevention methods for depression in high-familial-risk groups will not 
only need to include effective treatment of parental depression30,67,68, anxiety and irritability in 
the child, but will also need to consider social risk factors.  Family-based programs may be 
indicated in youth at high familial-risk of depression because parental depression is 
associated with social adversity (poverty and stress-exposure)69-71 and moderates the 
effectiveness of preventive programs focusing on the child30,72.  Our findings underscore the 
potent impact of social risks in the initial development of adolescent depression52,69,73,74.   
Whilst this study has a number of important strengths including the use of a large, 
prospective longitudinal high-risk study with repeated measurement using comprehensive 
psychiatric assessments allowing a novel focus on incident cases of new-onset MDD, low 
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rates of attrition across assessments, and use of a method appropriate for simultaneously 
modelling multiple correlated risk effects, results should be interpreted bearing in mind a 
number of considerations and limitations.  First, although the rates of MDD were higher than 
comparable community studies59, participants in this sample have not yet gone through the 
peak period of risk for MDD which occurs in early adult life and thus the numbers with MDD 
are relatively low.  However, results replicated for MDD symptom count.  Second, we 
selected clinical antecedents and indicators of familial and psychosocial risk on the basis of 
empirical evidence6,8,9,17,20,21,23,26,27,48.  However, it is inevitable that some variables viewed to 
be important because they are disrupted in major depression (e.g. parenting75, 
neuropsychological/cognitive dysfunction76) will have been omitted.  Measurement 
differences between constructs may also contribute to results, for instance, the clinical 
antecedent construct of fear/anxiety contained more items than that for irritability.  Third, we 
cannot rule out person effects on the environment i.e. that individuals to some extent ‘elicit’ 
environmental risk exposure through their behavior77,78  However, it seems unlikely that 
children ‘elicit’ economic adversity and evidence suggests causal effects of psychosocial 
adversity on MDD when accounting for inherited influences on environmental exposure79.  
Fourth, as would be expected, there were a relatively small number of males with MDD in 
the sample meaning that we were unable to assess gender differences in the pathways to 
first-onset MDD.  Gender differences in the pathways to life-time adult-onset MDD have 
reported80-82 and thus whether there are gender differences in the pathways to the incidence 
of adolescent-onset MDD will require future investigation. Joint analyses across multiple 
data sets may be needed which could also incorporate the gender of the parent.  Fifth, we 
assessed indicators of familial-risk for MDD using data from clinical interview as opposed to 
measured genotypes.  However, family-history provides complementary information to 
molecular genetic risk-scores83.  Sixth, the sample consisted overwhelmingly of depressed 
mothers making it unclear to what extent findings would generalize to the offspring of 
depressed fathers.   
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This study of children and adolescents at high familial-risk of MDD shows that 
fear/anxiety and irritability are important clinical antecedents of new-onset MDD but that 
familial and social risk factors additionally contribute to risk for the initial onset of adolescent 
MDD.  Primary prevention/early intervention strategies may need to target, not only clinical 
features in the high-risk child and the parent, but also incorporate public health and 
community strategies to help overcome social risks most notably poverty and psychosocial 
adversity.  
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Figure Legends 
 
Figure 1.  Structural equation model examining pathways to new-onset Major 
Depressive Disorder (MDD).  F.H: Family history; * p < .05; ** p<.01; Ɨ paths significantly 
differ. Dashed paths are not statistically significant.  
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Table 1: Descriptive statistics  
 
Construct Mean, SD (range) or  
percentage (n) 
 
Indicators of social and genetic risk (baseline)  
 
Additional family history a 0.75, 0.86 (0-6) 
 
Parent severe depression b 68% (205/303) 
 
Parent GAF score (worst episode) 
 
42.46, 17.45 (4-90) 
Economic disadvantage c  28.6% (80/280) 
 
Recent psychosocial  adversity d 3.30, 2.30 (0-12) 
 
Dimensional clinical antecedents (baseline)  
 
Irritability  1.33, 1.12 (0-3) 
 
Disruptive behavior  1.51, 1.79 (0-8) 
 
Fear/anxiety  23.49, 14.82 (0-63) 
 
Low mood 18.46, 13.18 (0-62) 
 
Primary and secondary outcomes (follow-up)  
 
New-onset MDD  
 
 
Age of onset 
 
7% (20/279) 
(14 Females; 6 Males) 
 
14.4, 2.33 (10, 18) 
 
Depressive symptoms  1.85, 1.74 (0-8.5) 
 
 
a Number of first and second degree relatives with depression weighted by relatedness 
b GAF score <50 or hospitalization for depression 
c Gross family income: proportion <£20,000 
d Number of recent stressful life events 
 
 
 
 
 
 
 
 
